Table 4.
Linear regression analysis, afe and animal/human oral bioavailability ratio.
Species | Number of points | Slope (β) | Intercept (α) | R2 | ccc | afe | Median RA/H | 5% lower percentile for RA/H | 95% upper Percentile for RA/H |
---|---|---|---|---|---|---|---|---|---|
All | 318 | 0.553⁎ | 33.114 | 0.342 | 0.548 | 0.647 | 0.866 | 0.082 | 2.771 |
Mouse | 30 | 0.507⁎⁎ | 39.478 | 0.253 | 0.444 | 0.593 | 0.784 | 0.058 | 2.784 |
Rat | 122 | 0.544⁎ | 35.759 | 0.287 | 0.470 | 0.583 | 0.723 | 0.075 | 2.777 |
Dog | 125 | 0.580⁎ | 26.433 | 0.374 | 0.605 | 0.845 | 0.990 | 0.236 | 3.254 |
NHP | 41 | 0.691⁎ | 32.942 | 0.694 | 0.698 | 0.417 | 0.592 | 0.051 | 1.042 |
Regression equation, FHuman = β * FAnimal,species + α; R2, coefficient of determination; ccc, concordance correlation coefficient; afe, average fold error; RA/H, animal and human oral bioavailability ratio.
p value vs. constant model < 0.001.
p value vs. constant model < 0.005.